Login
Related Links
Special News Items
- Team performs the first gene therapy tests in a whole human liver
- Gene Therapy Success in Hereditary Angioedema Patients
- FDA Approves CRISPR Gene Therapy to Treat Blood Disorder
- FDA Signals Imminent Approval for Sarepta’s Duchenne Gene Therapy: A Major Breakthrough for Patients
- Revolutionary gene therapy shows promise in treating autism
- Cell & Gene Therapy Space Gears Up for First CRISPR Approval
- Gene therapy restores hearing in children with rare form of deafness
- UK biotech AlveoGene launches with plans for inhaled gene therapy
- Gene Therapy Targets Chronic Pain
- Gene therapy eyedrops restored a boy's sight. Similar treatments could help millions
- Gene therapy approved by FDA for certain boys with rare genetic condition
- FDA Needs More Cell, Gene Therapy Mid Managers to Speed Reviews
- Biology Professor Venigalla Rao Makes Breakthrough on Gene Therapy Research
- Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS)
- Bacterial ‘Nanosyringe’ Could Deliver Gene Therapy to Human Cells
- EU approves Hemgenix, one-time gene therapy for hemophilia B
- FDA officials offer advice on gene therapy trials
- New gene therapy delivers treatment directly to brain
- FDA approves Ferring’s Adstiladrin as first gene therapy for bladder cancer
- FDA Approves First Gene Therapy for Hemophilia B
- FDA finalizes neurodegenerative disease gene therapy guidance
- Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness
- Codex DNA's BioXp 9600 System debuting at CAR-TCR Summit
- BioMarin reports cancer case in hemophilia gene therapy trial
- Novartis Confirms Deaths of Two Patients Treated with Gene Therapy Zolgensma
- First patient in the Netherlands successfully treated with stem cell gene therapy
- One-time gene therapy injection could provide HIV treatment that may last a lifetime
- Gene therapy to cure leukemia at one-tenth global costs in the works
- Gene Therapy Successfully Treats Spinal Cord Injuries Without Side Effects
- Updates on gene therapy for ‘bubble boy’ disease and cellular immunotherapy at ASGCT